Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Therapy Type
3.2. Snippet by End User
3.3. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Product Approvals
4.1.1.2. Growing Prostate Cancer Prevalence
4.1.2. Restraints
4.1.2.1. Stringent Regulatory Authorities
4.1.3. Opportunity
4.1.4. Government Initiatives
4.1.5. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Regulatory Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Post COVID-19 & Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. Global Recession Analysis
9. Artificial Intelligence Impact Analysis
10. By Therapy Type
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
10.1.2. Market Attractiveness Index, By Therapy Type
10.2. Hormone therapy
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Chemotherapy
10.4. Immunotherapy
10.5. Radiation
10.6. External-beam radiation therapy
10.7. Brachytherapy
10.8. Focal therapies
10.9. Cryosurgery
10.10. High-intensity focused ultrasound (HIFU)
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Surgical Centers
11.4. Specialty Clinics
11.5. Cancer Rehabilitation Centers
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.5.1. The U.S.
12.2.5.2. Canada
12.2.5.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.5.1. Germany
12.3.5.2. The U.K.
12.3.5.3. France
12.3.5.4. Italy
12.3.5.5. Spain
12.3.5.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.5.1. Brazil
12.4.5.2. Argentina
12.4.5.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.5.1. China
12.5.5.2. India
12.5.5.3. Japan
12.5.5.4. Australia
12.5.5.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapy Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. Johnson & Johnson
14.1.1. Company Overview
14.1.2. Therapy Type Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Astella, Inc.
14.3. Sanofi Aventis
14.4. IPSEN
14.5. Bayer AG
14.6. AstraZeneca
14.7. Valent Pharmaceuticals LLC
14.8. Sanofi-Aventis
14.9. Pfizer Inc.
14.10. Novartis International AG
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us